Ketamine in epilepsy treatment

Takeaway

  • Ketamine (KET) treatment is associated with decreased seizure burden and improved hemodynamics over time in patients with super-refractory status epilepticus (SRSE).

Why this matters

  • Super-refractory status epilepticus is associated with high mortality, and there is no available data supporting its optimal management.
  • Ketamine shows increased efficacy in SRSE treatment, with improved hemodynamics, and is relatively inexpensive; thus, incorporating it into early treatment plans for SRSE may provide significant benefits in outcomes for these patients, including decreased mortality rates.

Vuoi saperne di più?

Accedi o registrati per accedere a tutti i contenuti di Neurodiem.

Hai già un account? Accedi

Disclaimer Disclaimer, do not edit International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.